US Patent Issued to The Brigham and Women's Hospital on Sept. 30 for "Biomarker panels for on-treatment prediction of response to immuno-oncology drugs" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,429,485, issued on Sept. 30, was assigned to The Brigham and Women's Hospital Inc. (Boston).

"Biomarker panels for on-treatment prediction of response to immuno-oncology drugs" was invented by Alissa Keegan (Jamaica Plain, Mass.), David R. Walt (Boston) and Limor Cohen (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Biomarker panels for the prediction of patient response to immunotherapy, and methods of use thereof."

The patent was filed on Dec. 16, 2019, under Application No. 17/413,383.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetah...